In conclusion, Wnt pathway inhibition reduced PD-L1 expression in HCC cells by inhibiting its translation and enhanced the efficacy of PD-1 blockade, highlighting a promising avenue for improving immunotherapy outcomes in HCC. Here, PDCD1 is linked to hepatocellular carcinoma.